Literature DB >> 7693276

Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock.

C Thiemermann1, C C Wu, C Szabó, M Perretti, J R Vane.   

Abstract

1. This study investigates the role of tumour necrosis factor (TNF) in the induction of nitric oxide synthase (NOS) by bacterial endotoxin (lipopolysaccharide; LPS) in a rat model of endotoxin shock. 2. In anaesthetized rats, pretreatment with a monoclonal antibody for TNF (TNFab; 20 mg kg-1, s.c., at 16 h prior to LPS) ameliorated the fall in mean arterial blood pressure (MAP) in response to LPS (2 mg kg-1, i.v.). For instance, endotoxaemia for 180 min resulted in a fall in MAP from 114 +/- 6 (control) to 84 +/- 5 mmHg (P < 0.01; n = 7). In contrast, animals pretreated with TNFab prior to LPS injection maintained significantly higher MAP when compared to LPS-control (MAP at 180 min; 118 +/- 3 mmHg; P < 0.01, n = 5). 3. Three hours of endotoxaemia was also associated with a significant reduction of the contractile effects of noradrenaline (NA) (10(-8)-10(-6) M) on the thoracic aorta ex vivo. This hyporeactivity to NA was partially restored by in vitro treatment of the vessels with NG-nitro-L-arginine methyl ester (L-NAME, 20 min, 3 x 10(-4) M). Pretreatment of rats with TNFab (20 mg kg-1; at 16 h prior to LPS) significantly (P < 0.05) attenuated the LPS-induced hyporeactivity of rat aortic rings ex vivo. L-NAME did not enhance the contractions of aortic rings obtained from TNFab pretreated LPS-rats. 4. At 180 min after LPS there was a significant elevation of the induced NOS activity in the lung (5.14 +/- 0.57 pmol citrulline mg-1 min-1, n = 8). TNFab pretreatment significantly attenuated this induction of NOS in response to LPS by 37 +/- 6% (n = 5; P<0.05).5. We conclude that the formation of endogenous TNF contributes to the induction of the calcium in dependent isoform of NOS in response to LPS in vivo. Thus, the beneficial effects of agents which inhibit either the release or the action of TNF in circulatory shock may be, in part, due to inhibition of NOS induction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693276      PMCID: PMC2176026          DOI: 10.1111/j.1476-5381.1993.tb13789.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

Review 1.  Overproduction of nitric oxide in cytokine-mediated and septic shock.

Authors:  R G Kilbourn; O W Griffith
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

2.  Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle.

Authors:  J A Mitchell; H Sheng; U Förstermann; F Murad
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

Review 3.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

4.  Tumor necrosis factor-alpha induces vascular hyporesponsiveness in Sprague-Dawley rats.

Authors:  K Takahashi; K Ando; A Ono; T Shimosawa; E Ogata; T Fujita
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

5.  Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.

Authors:  J L Masferrer; K Seibert; B Zweifel; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  Time course of various inflammatory mediators during recurrent endotoxemia.

Authors:  B Klosterhalfen; K Hörstmann-Jungemann; P Vogel; S Flohé; F Offner; C J Kirkpatrick; P C Heinrich
Journal:  Biochem Pharmacol       Date:  1992-05-28       Impact factor: 5.858

7.  RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.

Authors:  A Floch; A Bousseau; E Hetier; F Floc'h; P E Bost; I Cavero
Journal:  J Lipid Mediat       Date:  1989 Nov-Dec

8.  Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis.

Authors:  C J Walsh; H J Sugerman; P G Mullen; P D Carey; S K Leeper-Woodford; G J Jesmok; E F Ellis; A A Fowler
Journal:  Arch Surg       Date:  1992-02

9.  Molecular regulation of tumor necrosis factor-alpha and lymphotoxin production in T cells. Inhibition by prostaglandin E2.

Authors:  N R Ferreri; T Sarr; P W Askenase; N H Ruddle
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

10.  In vivo and in vitro effects of endotoxin on vascular responsiveness to norepinephrine and signal transduction in the rat.

Authors:  E A Suba; T M McKenna; T J Williams
Journal:  Circ Shock       Date:  1992-02
View more
  29 in total

Review 1.  Role of cytokines in testicular function.

Authors:  D B Hales; T Diemer; K H Hales
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

2.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli.

Authors:  L Molina; S Studenberg; G Wolberg; W Kazmierski; J Wilson; A Tadepalli; A C Chang; S Kosanke; L Hinshaw
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

4.  Co-induction of nitric oxide and tetrahydrobiopterin synthesis in the myocardium in vivo.

Authors:  Y Hattori; S Hattori; S Motohashi; K Kasai; S I Shimoda; N Nakanishi
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

5.  Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia.

Authors:  C Szabó; G Haskó; B Zingarelli; Z H Németh; A L Salzman; V Kvetan; S M Pastores; E S Vizi
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

6.  Role of nitric oxide in the circulatory failure and organ injury in a rodent model of gram-positive shock.

Authors:  K M Kengatharan; S J De Kimpe; C Thiemermann
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.

Authors:  C C Wu; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

8.  Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats.

Authors:  S J De Kimpe; M L Hunter; C E Bryant; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

9.  Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.

Authors:  C C Wu; S J Chen; C Szabó; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Cloricromene in endotoxemia: role of NF-kappaB.

Authors:  A Ianaro; P Maffia; G Grassia; P Di Meglio; R Sorrentino; R d'Emmanuele di Villa Bianca; M Di Rosa; A Ialenti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-30       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.